GMO Quarterly Letter | 1Q 2017

Up At Night

Executive Summary

By analyzing the vulnerability of portfolios both against eternal risks and any particularly relevant risks, we have gained knowledge we can use to help us decide whether there are any risks it makes sense to hedge against today, as well as to help us alter the underlying asset mix to improve the portfolio’s robustness. Occasionally, markets will be sufficiently mispriced that we can get insurance for free, or actually be paid for it. Such times are to be treasured, but they are the exception rather than the rule. Most of the time, hedging and asset shifting decisions are not easy and involve trade-offs that have real costs to them, either in terms of lower expected returns or worse returns in a scenario that we may well care a good deal about. Our goal is to improve expected outcomes in the events we fear without paying too large a price in lower expected returns or increased risks against other scenarios. This is not always possible, and when it isn’t, we’ll suffer some insomnia. Losing sleep isn’t fun, but overpaying for sleep aids will wind up hurting in the long run.

Download to read the full article.

Disclaimer: The views expressed are the views of Ben Inker through the period ending May 2017, and are subject to change at any time based on market and other conditions. This is not an offer or solicitation for the purchase or sale of any security and should not be construed as such. References to specific securities and issuers are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities.
Copyright © 2017 by GMO LLC. All rights reserved.
Subscribe to GMO Research